Skip to content

Drug interactions

Larotrectinib + Ulipristal

Severity: Minor

Larotrectinib and Ulipristal: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Larotrectinib is a CYP3A4 substrate with possible weak inhibitory effect, so a small rise in ulipristal exposure is theoretically possible. Clinical relevance is unlikely with single-dose ulipristal.

What this interaction means in plain words

Larotrectinib and Ulipristal have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Evidence level: Low

Why it happens

Possible weak CYP3A4 inhibition; not well established.

What to do

No specific adjustment is required; be aware of possible increased ulipristal adverse effects.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Larotrectinib and Ulipristal, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Larotrectinib with Ulipristal?

MediHelp rates the interaction as minor. Larotrectinib and Ulipristal have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Larotrectinib is a CYP3A4 substrate with possible weak inhibitory effect, so a small rise in ulipristal exposure is theoretically possible. Clinical relevance is unlikely with single-dose ulipristal.

How serious is the interaction between Larotrectinib and Ulipristal?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: No specific adjustment is required; be aware of possible increased ulipristal adverse effects.

What other medicines interact with Larotrectinib?

MediHelp also lists interactions of Larotrectinib with, for example, Amobarbital, Apalutamide, Carbamazepine. The full list is on the Larotrectinib page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in